Study details
Enrolling now
Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
Tandem Diabetes Care, Inc.
NCT IDNCT07325461ClinicalTrials.gov data as of Apr 2026
Target enrollment
20
Study length
about 1 year
Ages
18–80
Locations
1 site in CA
What this study is about
This trial is testing different SteadiSet insulin infusion set options for people with type 1 diabetes to see if they are safe and practical to use at home. Participants will wear the SteadiSet infusion set for up to 7 days each, using either a t:slim X2 or Mobi pump. The study lasts for 365 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive SteadiSet Infusion Set
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Injection / IV
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug routes
intravenous
Devices
therapeutic
Body systems
Endocrinology